Fundraising FoxSynVaccine
2 known investors
Find your way into SynVaccine
Sign up to see every warm intro you have to SynVaccine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SynVaccine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.
Founders & leadership
TT
Tamir TullerCo-founder & CSO
OB
Oren BoginInterim CEO
DZ
David ZigdonExecutive Chairman
Investors · 2
Frequently asked questions
- What does SynVaccine do?
- SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.
- Who founded SynVaccine?
- SynVaccine was founded by Tamir Tuller.
- Who are SynVaccine's investors?
- SynVaccine's investors include Pix Vine Capital, Sapir Venture Partners.